Hoechsmann, B., Schafhausen, P., Beier, F., Heuser, M., Westermann, J., Drexler, B., Röth, A., Hänel, M., Sicre-de-Fontbrune, F., Marx-Hofmann, A., Beitzen-Heineke, A., Panse, J., Thol, F. R., Koerper, S., Brümmendorf, T. H., Schrezenmeier, H. (2025). Adding eltrombopag to immunosuppressive treatment with cyclosporine as front-line therapy for moderate aplastic anemia improves trilineage hematologic response: One-year analysis of the randomised, placebo-controlled, double-blind Phase III trial eltrombopag for moderate aplastic anemia (EMAA Trial). Blood. https://doi.org/10.1182/blood-2025-980